Sinovac, Sinopharm Omicron-specific vaccine candidates approved for clinical trial in Hong Kong Ruchika Sharma18 April 2022 11:55 AM ISTThe Sinopharm candidates will be tested as boosters in adults who have already received two or three vaccine doses, CNBG said.
Health Bulletin 16/April/2022 Dr. Nandita Mohan16 April 2022 6:45 PM ISTMedical Seats in Gujarat up from 1100 to 6000: PM Modi Medical seats in Gujarat have seen a record increment from 1100 to 6000 with more than a dozen...
FDA authorises first ever breath test for diagnosing COVID-19 Dr. Kamal Kant Kohli16 April 2022 11:30 AM ISTFirst test that can detect COVID-19 virus in breath sample received emergency use authorization (EUA) by The US food and drug administration.The test...
Health Bulletin 15-April-2022 Dr. Nandita Mohan15 April 2022 5:46 PM ISTHere are the top health stories for the day :Fourth shot protects against severe Omicron outcomes; According to a study from Israel...
New XE variant of COVID is just another form of Omicron Roshni Dhar14 April 2022 4:15 PM IST"The XE variant is a combination or recombinant of both sub-variants - BA.1 and BA.2 - of Omicron. "No new variant of Covid has been detected this...
Health bulletin 13/April/2022 Roshni Dhar13 April 2022 5:54 PM ISTHere are the top health stories for the day:No absolute right for individuals to set up medical colleges: SCReiterating the opinion given by the...
XE symptoms may include loss of taste and smell, says experts Roshni Dhar12 April 2022 3:40 PM ISTThe XE variant may trigger a loss of taste and smell which had been a prominent feature of the deadly Delta variant , a dominant variant during 2nd...
Study says Bharat Biotech Covaxin booster enhances antibody response against COVID variants including Omicron Ruchika Sharma10 April 2022 11:30 AM IST"The data emphasises the need for speedup of the booster doses to individuals for dealing with emerging VOCs and its outcome to protect against death,...
Health Ministry denies detection of XE variant in India Roshni Dhar8 April 2022 12:00 PM ISTIn response to the media reports that claimed that a case of the new mutant was reported in Mumbai, the Union Health Ministry said that present...
GSK-Vir COVID therapy Sotrovimab authorization junked by USFDA Roshni Dhar8 April 2022 11:17 AM ISTThe U.S. health regulator said on Tuesday GlaxoSmithKline and Vir Biotechnology's antibody therapy was no longer authorized as a COVID-19 treatment,...
USFDA junks authorization of GSK- Vir COVID therapy Sotrovimab Ruchika Sharma6 April 2022 4:20 PM ISTSotrovimab is no longer authorized to treat COVID-19 in any US region due to increases in the proportion of COVID-19 cases caused by the Omicron BA.2...
You can't turn blind eye to new XE variant Roshni Dhar4 April 2022 5:24 PM ISTThe World Health Organisation (WHO) has issued a warning against a new mutant 'XE' variant of Omicron, that may be more transmissible than any strain...
